Aptorum Group Ltd. and DiamiR Biosciences Announce Definitive Agreement for Merger, Aiming to Advance Brain Health Solutions

Reuters
07-23
Aptorum Group Ltd. and DiamiR Biosciences Announce Definitive Agreement for Merger, Aiming to Advance Brain Health Solutions

Aptorum Group Limited, a clinical stage biopharmaceutical company, announced a definitive agreement to merge with DiamiR Biosciences. The all-stock transaction will result in DiamiR becoming a wholly-owned subsidiary of Aptorum Group. Aptorum Group plans to remain listed on the Nasdaq Stock Market after the merger. The collaboration aims to leverage DiamiR's expertise in developing innovative blood-based tests for brain health and other diseases, enhancing the combined company's ability to address unmet medical needs in oncology and infectious diseases. The merger is expected to create a global life sciences company with a strong focus on non-invasive testing for brain health and other complex conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-066642), on July 22, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10